n.petrov

TL2 Moderator · Recife

Contributes reviews on supplier material. Based in Recife.

Joined 4 August 2025 · last posted 2d

71 posts, newest first. Showing up to 150.

Journal club: what we got wrong in an earlier session Replied, post #122 · Evidence › Journal club · 26 Jul 2026 · 5 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Revisiting: The best-written scientific paper you have read Replied, post #98 · Lounge › Off topic · 17 Jul 2026 · 0 likes post #97 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Reading a home test result without over-claiming Replied, post #123 · Analytics › Home & field testing · 17 Jul 2026 · 8 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #55 · Practice › Side effects · 17 Jul 2026 · 26 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
Tracking a shortage from primary sources rather than rumour Replied, post #102 · Access › Shortages · 14 Jul 2026 · 0 likes I read post #100 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Manufacturer assistance programmes and their eligibility rules Replied, post #42 · Access › Pricing · 13 Jul 2026 · 2 likes Coming back to post #40, because the follow-up matters more than the original answer. Discount programmes and coupons: manufacturers often offer coupons that reduce…
What is genuinely unknown about long-term amylin agonism Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Pooling trials with different estimands Replied, post #86 · Evidence › Meta-analyses · 10 Jul 2026 · 15 likes Coming back to post #84, because the follow-up matters more than the original answer. Funnel plots: a plot of study effect size versus sample size that helps detect…
Second pass at: Reading a trial's population section before its results Replied, post #2 · Evidence › Trials · 28 Jun 2026 · 21 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 21 Jun 2026 · 25 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #15 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes This follows post #12 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
Coming back to: Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #52 · Analytics › HPLC & UHPLC · 3 Jun 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #20 · Analytics › COA interpretation · 1 May 2026 · 1 like Worth separating two things that post #16 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Second pass at: Metformin co-administration and additive GI effects Replied, post #87 · Practice › Interactions · 17 Apr 2026 · 2 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #20 · Devices › Syringes & needles · 10 Apr 2026 · 0 likes post #19 answers the question as asked. The question underneath it is different. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #66 · Practice › Side effects · 9 Apr 2026 · 0 likes Picking up post #63: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
Managing an unplanned gap in supply Replied, post #74 · Access › Shortages · 26 Mar 2026 · 12 likes Coming back to post #72, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
Second pass at: Identical chromatograms across two different lots Replied, post #78 · Sourcing › Red flags · 19 Mar 2026 · 20 likes Picking up post #75: that is the part I would want checked first. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not…
Research-use-only labelling: what it means and what it does not Replied, post #97 · Sourcing › Regulatory · 3 Feb 2026 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
Reconstitution volumes that produce round numbers, tabulated Replied, post #31 · Practice › Reconstitution · 23 Jan 2026 · 2 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
Request: a diff view for wiki revisions — the long version Replied, post #92 · Meta › Feature requests · 31 Dec 2025 · 20 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
Named, unnamed and unspecified impurities as regulatory categories Replied, post #3 · Analytics › Impurities & related substances · 31 Dec 2025 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #21 · Regional › UK & Ireland · 29 Dec 2025 · 16 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Micro-titration: a disputed topic, argued properly Replied, post #5 · Practice › Dosing & titration · 21 Nov 2025 · 1 like Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Reading an interaction checker output critically Replied, post #46 · Practice › Interactions · 18 Nov 2025 · 9 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
DXA precision and the least significant change for lean mass Replied, post #6 · Outcomes › Body composition · 18 Nov 2025 · 2 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
Run-in periods and the population they select Replied, post #23 · Evidence › Trials · 17 Nov 2025 · 2 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Lyophilisation and why the cake looks the way it does Replied, post #24 · Pharmacology › Formulation chemistry · 9 Nov 2025 · 10 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
How to ask about something you suspect is a bad idea Replied, post #15 · Start Here › How to Ask · 10 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #98 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #86 · Evidence › Preprints · 2 Oct 2025 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
Second pass at: Programming during a large energy deficit Replied, post #12 · Nutrition & Training › Resistance training · 19 Sep 2025 · 16 likes post #11 answers the question as asked. The question underneath it is different. Recovery: heavier training on a energy deficit and on a compound that slows gastric…
Washout: how long is long enough, and for what purpose Replied, post #68 · Pharmacology › Pharmacokinetics · 19 Sep 2025 · 1 like post #67 answers the question as asked. The question underneath it is different. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #13 · Clinical › Special populations · 24 Aug 2025 · 1 like Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #43 · Start Here › How to Ask · 24 Aug 2025 · 10 likes post #42 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Substitution between formats during a shortage Replied, post #42 · Access › Shortages · 20 Aug 2025 · 1 like Coming back to post #40, because the follow-up matters more than the original answer. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
Titles that describe the question, not the situation Replied, post #75 · Start Here › How to Ask · 19 Aug 2025 · 6 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
A preprint whose numbers changed substantially at publication Replied, post #18 · Evidence › Preprints · 13 Aug 2025 · 7 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
Where the integrator drew the baseline, and how much it moved the number Replied, post #2 · Analytics › HPLC & UHPLC · 6 Aug 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #27 · Compounds › Repair & healing peptides · 6 Aug 2025 · 2 likes Worth separating two things that post #23 runs together. The distinction between "no evidence it works" and "evidence it does not work": we have the first for these…
Coming back to: When "no data" is the complete and final answer Replied, post #57 · Compounds › Other compounds · 24 Jul 2025 · 28 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #3 · Practice › Side effects · 23 Jul 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #39 · Evidence › Journal club · 11 Jul 2025 · 29 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Anxiety in the first weeks: drug, situation, or both Replied, post #107 · Wellbeing › Mental health · 24 Jun 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] An appeal that failed, and what I would do differently Replied, post #128 · Access › Insurance & coverage · 15 Jun 2025 · 16 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #96 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #20 · Data & Tools › Calculators · 8 Jun 2025 · 1 like Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Random versus fixed effects: choosing rather than defaulting Started this topic · Evidence › Meta-analyses · 7 Jun 2025 · 13 likes Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med ,…
Price changes over 2025 and 2026, tabulated and dated Replied, post #6 · Access › Pricing · 6 Jun 2025 · 5 likes Worth separating two things that post #2 runs together. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #80 · Practice › Reconstitution · 3 Jun 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
A well-designed study with a badly written abstract Replied, post #119 · Evidence › Study critique · 31 May 2025 · 0 likes This follows post #116 rather than contradicting it. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The…
Trial registration and comparing the protocol with the paper Replied, post #11 · Evidence › Trials · 30 May 2025 · 11 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
A claim built entirely on a subgroup analysis Replied, post #5 · Evidence › Study critique · 25 Apr 2025 · 9 likes On the opening post — agreed on the reasoning, with one qualification. What makes a methodological criticism substantive: it identifies a specific feature of the design…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #16 · Access › Pricing · 8 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Telehealth prescribing models in the US Replied, post #65 · Regional › North America · 2 Mar 2025 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #50 · Evidence › Meta-analyses · 4 Feb 2025 · 6 likes I read post #48 twice before replying, because I had assumed the opposite. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria.…
Filing a first vendor report: a worked example Started this topic · Sourcing › Vendor reports · 18 Jan 2025 · 3 likes Filing a first vendor report: a worked example Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #53 · Compounds › Other compounds · 1 Jan 2025 · 2 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Promotion criteria, and the one that stops most nominations Replied, post #138 · Documentation › Doc review · 12 Dec 2024 · 4 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #28 · Compounds › Secretagogues & GH axis · 11 Dec 2024 · 6 likes post #27 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #10 · Practice › Interactions · 27 Nov 2024 · 1 like post #9 is right about the mechanism and I think understates the practical bit. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #69 · Clinical › Special populations · 25 Nov 2024 · 2 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #114 · Clinical › Comorbidities · 27 Oct 2024 · 26 likes Worth separating two things that post #110 runs together. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN…
Irish differences from the UK position Replied, post #40 · Regional › UK & Ireland · 16 Oct 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #105 · Access › Shortages · 13 Oct 2024 · 10 likes post #104 is right about the mechanism and I think understates the practical bit. International supply chains: a shortage in one country does not mean shortage in…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #10 · Access › Shortages · 8 Oct 2024 · 21 likes post #9 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose…
When "no data" is the complete and final answer Started this topic · Compounds › Other compounds · 5 Oct 2024 · 22 likes Asking directly, because I could not find a straight answer: When "no data" is the complete and final answer I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #52 · Clinical › Bloodwork · 24 Sep 2024 · 0 likes I read post #50 twice before replying, because I had assumed the opposite. Reference intervals: constructed to contain the central 95% of a reference population, which…
Circumference measurements as a poor man's composition estimate Replied, post #109 · Outcomes › Body composition · 29 Aug 2024 · 23 likes On post #105 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Cold packs, phase-change material, and what survives ten days Replied, post #14 · Sourcing › Logistics · 14 Jun 2024 · 10 likes On post #10 — agreed on the reasoning, with one qualification. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will…